New technology may prolong the life of implanted devices, from pacemakers to chemotherapy ports

Aug 23, 2010

By creating a unique system of blood vessels that is engineered to interact with the tissue surrounding an implanted device, the longevity and function of these devices may be better preserved, according to a study led by researchers in the University of Louisville/ Jewish Hospital's Cardiovascular Innovation Institute (CII).

The study was published early online on August 23, 2010 in the Journal of Biomedical Materials Research and was funded by the National Institutes of Health.

"One of the biggest problems with any kind of implanted device, such as , a chemotherapy port or the glucose sensors necessary to monitor in diabetic patients, is the body's natural reaction to recognize it as foreign and form a scar around it," said Stuart Williams, PhD, scientific director of the CII and a senior investigator on the study. "Scars have very little and because this connection between the body and the device is compromised, the function of the device over time can decline, threatening health and leading to additional interventions to replace it."

The researchers sought to prevent the formation of around an implanted device by "pre-vascularizing" the device just prior to implantation. The investigators call this a microvascular construct (MVC) consisting of tiny blood vessel fragments suspended in a collagen gel. The combination of the MVC, already rich with , and the device appears to provide an environment that resists the formation of scar tissue once the device is implanted, Williams said.

"This study built on our earlier work that showed that this material, what we call an MVC, stimulates circulation and prevents scarring when implanted in the body, in animal models," said James Hoying, PhD, director of cardiovascular therapeutics at the CII and a senior investigator on this study. "We wanted to next see if we could maintain that circulation in order to prevent scarring over the long term and thus prolong the function of any number of implanted devices."

The researchers compared the tissue surrounding a bare expanded polytetrafluoroethylene material - implanted biomaterial many devices are made of - embedded in collagen alone to one embedded in collagen and the MVC, and found that the latter both promoted and maintained circulation in the area around the implant, Williams said. Animal models were used. Collagen is a naturally occurring protein found in the flesh and connective tissue of animals and humans. It has been found to mediate the inflammatory reaction that often occurs when an implanted device interacts with surrounding tissue.

"We found that the presence of the MVCs and collagen altered the way tissue formed around the implants, restricting the formation of scar tissue because there was so much blood vessel activity," Williams said. "The presence of the MVCs and collagen also reduced the number of white blood cells that stimulate inflammation, where the device was implanted. The vessels associated with the implant were seen to be capable of sustainable delivery over time."

All of these factors are important in sustaining circulation and suppressing scar formation, he said.

Williams and colleagues are now working to design an operating room-compatible device that could bring this technology to patients.

"This could have implications for patients who have any number of implantable devices, from those on dialysis to patients with devices that help failing hearts to function, to those receiving chemotherapy, catheters and multiple other indications," Williams said.

Explore further: Reconstruction of a patterned piece of spinal cord in 3D culture

Provided by University of Louisville

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Skin care: new research into scar-free healing

Jan 21, 2008

New research from the University of Bristol shows that by suppressing one of the genes that normally switches on in wound cells, wounds can heal faster and reduce scarring. This has major implications not ...

Blood vessels made from patients' cells

Apr 24, 2009

(AP) -- Scientists have grown blood vessels for kidney patients from their own cells, making it easier and safer for them to use dialysis machines, a new study says.

Engineering electrically conducting tissue for the heart

Jun 19, 2006

Patients with complete heart block, or disrupted electrical conduction in their hearts, are at risk for life-threatening rhythm disturbances and heart failure. The condition is currently treated by implanting ...

Blood protein triggers scars in the brain after injury

Apr 27, 2010

A protein called fibrinogen that is known to help form blood clots also triggers scar formation in the brain and spinal cord, according to new research in the April 28 issue of the Journal of Neuroscience. Resear ...

DNA layer reduces risk of reserve parts being rejected

Mar 20, 2007

Dutch researchers Jeroen van den Beucken and John Jansen have given body implants a DNA layer. This layer ensures a better attachment, more rapid recovery of the surrounding tissue and less immune responses. ...

Recommended for you

Unlocking the secrets of pulmonary hypertension

7 hours ago

A UAlberta team has discovered that a protein that plays a critical role in metabolism, the process by which the cell generates energy from foods, is important for the development of pulmonary hypertension, a deadly disease.

New molecule sneaks medicines across the blood/brain barrier

12 hours ago

Delivering life-saving drugs across the blood-brain barrier (BBB) might become a little easier thanks to a new report published in the November 2014 issue of The FASEB Journal. In the report, scientists describe an antibo ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.